Todd A. Meyer, DO, FAOCO, FAAOA

Size: px
Start display at page:

Download "Todd A. Meyer, DO, FAOCO, FAAOA"

Transcription

1 Todd A. Meyer, DO, FAOCO, FAAOA

2 None vivianpaige.com

3 Atopic Dermatitis Epidemiology Pathophysiology Diagnosis Management

4

5 2 year old female New widespread rash on her face, arms, abdomen, and behind both knees. Rash has been present for the last two weeks and seems to be getting worse. Patient is scratching uncontrollably while sitting on her mothers lap. Mother states that this scratching is negatively affecting her sleep. Previous to this rash the child has been healthy, up to date with immunizations and at the 50th percentile for height ht and weight. She has a good appetite and has no gastrointestinal complaints. There have been no sick contacts or recent travel.

6 Additional pertinent history: Mother has asthma and allergic rhinitis (Major diagnostic criteria) No sun exposure, new soaps, detergents, lotions, clothing, bedding, etc. Patient has several potential infant triggers: PMH: Unremarkable PSH: None Allergies: NKDA

7 Family History: Mother with asthma and allergic rhinitis 1. Foods such as eggs, milk, and soy in the diet. 2. The family has a dog 3. No smoke exposure Physical exam: The rash is particularly severe in the popliteal fossa. The rash generally has a fine papular p appearance with some slight scaling and prominent erythema on the face, arms abdomen, there is sparing of the diaper area. There are no crusts, pustules or exudates HEENT: Positive for Dennie Morgan lines, periorbital darkening Otherwise unremarkable exam with normal vitals

8 Is made through history and appearance Di t ib ti f ki Distribution of skin lesions!

9 In 1980, Hanifin and Rajka developed criteria for the diagnosis of AD. They developed main criteria and numerous minor criteria. Many articles have questioned the validity of the minor criteria, and the original criteria have been modified on numerous occasions. Following are the criteria for Essential features: These features must be present and, if complete, are sufficient for diagnosis. Pruritus Eczematous changes Typical and age-specific changes: Patterns include facial, neck, and extensor involvement in infants and children, current or prior flexural lesions in adults or persons of any age, and sparing of the groin and axillary regions. Chronic and relapsing course Important features (seen in most cases): These features are seen in most cases and add support to the diagnosis Early age of onset Atopy (IgE reactivity) Xerosis Associated features (clinical associations): These changes help in suggesting the diagnosis of AD but are too nonspecific to be used for defining or detecting AD for research and epidemiologic studies. Keratosis pilaris/ichthyosis/palmar hyperlinearity Atypical vascular responses Perifollicular l changes Ocular/periorbital changes Perioral/periauricular lesions Exclusions: Note that a firm diagnosis of AD depends on excluding conditions such as scabies, allergic contact dermatitis, seborrheic dermatitis (SD), cutaneous lymphoma, ichthyosis, psoriasis, and other primary disease entities. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;92 (suppl):44-7.

10 According to the criteria of Williams et al, proposed diagnostic guidelines include the following: Patients must have an itchy skin condition (or parental report of scratching or rubbing in children). Patients also must have 3 or more of the following: History of involvement of the skin creases, such as folds of the elbows, behind the knees, fronts of the ankles, or neck Personal history of asthma or hay fever or a history of atopic disease in a first-degree relative in patients younger than 4 years History of generally dry skin in the last year Visible flexural dermatitis or dermatitis involving the cheeks or forehead and outer limbs in children younger than 4 years Onset younger than age 2 years (not used if child is <4 y)

11 Essential Features (3 of 4 Required) Pruritus Facial and extensor eczema in infants and young children/flexural eczema in older children and adults Chronic or relapsing dermatitis Personal or family history of atopic disease

12 allergyasthma.wordpress.com skin-disease.org travinka.ru

13 Xerosis Cutaneous infections Cheilitis Non-specific dermatitis of hands and feet Elevated serum IgE Positive allergy skin tests Early age at onset Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh). 1980;92 (suppl):44-7.

14 Ichthyosis jaskin.com Palmar Hyperlinearity y medicaljournals.se Keratosis Pilaris emedicine.medscape.com

15 Pityriasis alba vitiligoarab.net t White dermatographism and delayed blanch response kmle.co.kr Anterior subcapsular cataracts, Keratoconus

16 Dennie-Morgan infra-orbital folds Orbital Darkening University of Iowa Dermatology 1997 Facial erythema or pallor medicine-article.com

17 Prevalence 10-20% Children, hld 1-3% Adults Higher in industrialized nations Higher in urban vs. rural regions More common in higher social class Up to 85% develop symptoms before age 5 Symptoms frequently present in early infancy 45% before 6 months, 60% before age 1 year 30% develop asthma 35% develop allergic rhinitis Horii KA, Simon SD, Liu DY, Sharma V. Atopic dermatitis in children in the United States, : visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics. Sep 2007;120(3):e [Medline]. Schultz-Larsen, Immunol Allergy Clin North Am 2002; 22: 1-24 Taylor, Lancet 1984; 2: Williams, Atopic Dermatitis, 2000: Luoma, Allergy 1983; 38:

18 Aberg (1995) Questionnaire study of Swedish School Children ( year-olds) in 1979 and 1991 Prevalence of AD more than doubled (7% to 18%) Sugiura(1998) 7000 Japanese school children examined Prevalence of AD in 9-12 year-olds doubled d compared to 20 years earlier 18 year-olds had a 5-fold increase in prevalence over 20 years Aberg, Clin Exp Allergy 1995; 25: Sugiura, Acta Derm Venereol 1998;

19 Atopic Dermatitis seems to be the Entry Point for the development of allergic disease Bustos, Clin Exp Allergy 1995; 25:

20 Should AD children be targeted for asthma prevention? YES! Children with AD, age 1-36 months, treated with daily antihistamine (randomized, placebo controlled) 25% fewer diagnoses of asthma in the anti-histamine group ETAC Study 817 infants, age 1-2, treated with placebo or cetirizine 50% developed asthma, but 25% less in cetirizine treated patients who had specific sensitizations to dust or grass Bustos, Clin Exp Allergy 1995; 25: Warner, ETAC Study Group, J Allergy Clin Immunol 2001; 108:

21 60% of AD children are symptom free by early adolescence 50% may recur in adulthood Predictors of persistent disease course: Early onset, severe early disease, asthma and hay fever, and family history Evidence of food and inhalant allergy by age 2 also predicts severe disease Lammintausta, Int J Dermatol 1991; 30: Illi, J Allergy Clin Immunol 2004; 113:

22 Two types of atopic dermatitis Extrinsic i Associated with IgE-mediated sensitization 70-80% of patients Intrinsic Absence of IgE-mediated sensitization 20-30% of patients Types of AD are identical clinically

23 Infantile Phase exudative, erythematous papules and vesicles Face, trunk, extensor surfaces Childhood Phase lichenified papules and plaques Hands, feet, wrists, ankles, antecubital, popliteal Adult Phase dry, scaling, erythematous papules and plaques with large lichenified ed plaques Flexural folds, face, neck, upper arms, back, dorsa of hands, feet, fingers, and toes

24 Most have peripheral blood eosinophilia and increased serum IgE Increased allergen-specific Th2-cells IL-4 and-13 Isotype switching to IgE Induce expression of VCAM-1 (eosinophil infiltration) Downregulate Th1 cytokines IL-5 Development, activation, and survival of eosinophils Hamid, J Clin Invest 1994; 94:

25 Food allergy induces skin rash in 40% of children with AD Can be diagnosed with IPDFT, elim/challenge or mrast Most commonly egg, milk, wheat, soy, and peanut T-cells specific for foods have been cloned from skin lesions Sampson, J Allergy Clin Immunol 1999; 103: Van Reijsen, J Allergy Clin Immunol 1998; 101:

26 Double-Blind, Placebo Controlled Oral Food Challenges Food allergens caused increased symptoms Symptoms resolved when food was eliminated Sicherer, J Allergy Clin Immunol 1999; 104

27 Sensitization to aeroallergens correlates with severity of AD Inhalation challenge in sensitized individuals can exacerbate pruritus and skin lesions Proper avoidance measures in dust sensitive patients has led to improvement in AD Immunotherapy is not universally helpful Recent study showed improved AD when dust allergy is treated with immunotherapy Capristo, Allergy 2004; 59(suppl 78):53-60 Schafer, J Allergy Clin Immunol 1999; 104: Scalabrin, J Allergy Clin Immunol 1999; 104: Holm, Allergy 2001; 56: Werfel, Allergy 2006; 61:

28 Atopy Patch Testing Mostly used for research Occlusive patch testing with aeroallergens elicits eczematoid reactions in 30-50% of AD patients Allergic patients without AD have no reaction to this patch test Wheatley in Leung, Allergic Skin Disease: A Multidisciplinary Approach 2000; 423

29 Multipronged Approach Skin Care Identification and Elimination of Triggers Anti-pruritus Treatment Anti-inflammatory inflammatory Treatment

30 Clinical Recommendation Evidence Rating References Emollients are the mainstay of maintenance therapy for 3, 4, 10 atopic dermatitis. B Topical corticosteroids should be first-line treatments for patients with atopic dermatitis flare-ups. Sedating antihistamines are indicated for the treatment of atopic dermatitis when patients have sleep disturbances and concomitant allergic conditions. A A Antibiotics should be reserved for the treatment of acutely 4 infected lesions associated with atopic dermatitis. A Topical calcineurin inhibitors should be second-line treatments for atopic dermatitis flare-ups and maintenance. A A =consistent, good-quality patient-oriented evidence; B =inconsistent or limited-quality patient-oriented evidence; C =consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, see page 453 or / f

31 Liberal amounts of a lubricant or emollient cream should be applied to the skin immediately after bathing. Emollients should be applied once or twice daily to prevent skin dryness and irritation. Patients generally prefer emollient creams over ointments for daytime use because emollients have a non greasy, cosmetic appearance. Lubricating ointments may be preferred for nighttime use because of their superior hydrating properties. Wearing cotton gloves or socks at night may enhance these properties.

32 Numerous studies have evaluated a variety of dietary, environmental, and alternative approaches to the prevention of atopic dermatitis flareups. [3] [4] [11] Scratch-itch-scratch behavior Begins with habitual scratching Perpetuates dry, irritated skin Can be effectively modified with psychological treatment. [12 TABLE 2 -- Unproven Prevention and Treatment Strategies for Atopic Dermatitis Information from reference 4. Chinese herbal therapy Delayed introduction of solid foods in infants Dietary restrictions Homeopathy Massage therapy Prolonged breastfeeding Reduction of house mite dust Salt baths Use of different diaper materials

33 Use soft Clothing next to the skin. Cotton is comfortable Can be layered in the winter. Wool products should be avoided. Clothes should be washed in a mild detergent with no bleach or fabric softener. Cool temperatures, particularly l at night, are helpful Sweating causes irritation and itch. A humidifier (cool mist) prevents excess drying Used in both winter, when the heating dries the atmosphere, and in the summer, when air conditioning absorbs the moisture from the air. Food avoidance

34 Want to maintain moist skin at all times Soak in clean, warm water (bath, not shower) Avoid soap at every bath Use gentle non-drying soaps (Aveeno, Dove, Basis, Neutrogena) minimal defatting and neutral ph Avoid bath oils Avoid scrub brushes and washcloths

35 Pat dry after the bath While skin is still moist, apply an emollient (Aquaphor, Eucerin, Cetaphil, Neutrogena) Petroleum jelly, mineral oil, or Crisco can be used if xerosis is severe realsimple.com

36 When rash leads to open, oozing sores: Frequent baths (4 per day) in clean, warm water Add colloidal oatmeal to the bath water (3 tbsp) Avoid irritants! omurtlak.bloguez.com

37 Soaps and detergents Want minimal i defatting activity i and neutral ph Wash clothes in gentle, liquid detergent and add extra rinse cycle Heat and perspiration Occlusive clothing Loose fitting cotton, silk, and cotton blends are best Sunburn

38 Identify potential allergens through history and skin testing or mrast Foods are very important and proper elimination / rotation diets should be used Immunotherapy for AD has not been proven to be beneficial Reserve for patients with clear seasonal exacerbations or other symptoms of allergic disease

39 Proper bathing and emollients may be enough Add antihistamine if needed Cetirizine, loratadine, desloratadine, fexofenadine, diphenhydramine, hydroxyzine Try non-sedating in morning and sedating at night to help with sleep Topical Doxepin works well, but is sedating

40 Increased colonies of S aureus in 90% of AD skin lesions Improved response to therapy when anti-staph antibiotics are included Superantigen production is the likely mechanism Leyden, Br J Dermatol 1977; 96: Breuer, Allergy 2000; 55:

41 Scratching enhances binding Exposes extracellular l matrix adhesins Th2 inflammatory responses promote binding IL-4 induces fibronectin expression AD skin is deficient in antimicrobial peptides (βdefensins) Cho, J Invest Dermatol 2001; 116: Ong, N Engl J Med 2002; 347: Cho, J Allergy Clin Immunol 2001; 108:

42 Topical mupirocin (Bactroban) works well when Staph colonization i is present (almost always) Treat the nose, too! Watch for super-imposed HSV infection

43 Reduce inflammation and pruritus in acute and chronic AD Goal is to use the lowest strength possible to control o symptoms s Ointments are generally preferred over cream / gel More occlusive and fewer additives

44 Thinning skin Telangiectasias Bruising Hypopigmentation Acne Striae Face and intertriginous areas are more susceptible to these events Low Potency formulations only! Elidel and Protopic for the Treatment of Eczema, Black Box Warning on Elidel and Protopic by Daniel More, MD, About.com Guide Updated September 08, 2011 Acta Derm Venereol Suppl (Stockh). 1989;151:26-30; discussion Adverse effects of topical corticosteroids. Piérard GE, Piérard-Franchimont C, Ben Mosbah T, Arrese Estrada J. Department of Dermatopathology, University of Liège, Belgium

45 Least Potent to Most Potent Group 7 Hydrocortisone (Hytone) 1 and 2.5% oint/cream Group 6 Desonide (DesOwen).05% oint/cream/lotion Alclometasone (Aclovate).05% oint/cream Group 5 Fluocinolone (Synalar).025% cream Hydrocortisone valerate (Westcort).2% oint Group 4 Mometasone (Elocon).1% cream Fluocinolone (Synalar).025% oint Triamcinolone (Kenalog).1% oint/cream Group 3 Fluticasone (Cutivate).005% oint Halcinonide id (Halog).1% oint Betamethasone (Valisone).1% oint Group 2 Mometasone (Elocon).1% oint Halcinonide (Halog).1% cream Fluocinonide (Lidex).05% oint/cream Desoximetasone (Topicort).25% oint/cream Group 1 Betamethasone (Diprolene).05% (ointment, gel) Clobetasol (Temovate).05% oint/cream Hengge, U, Ruzicka, T, Schwartz, R, and Cork, M. ÒAdverse Effects of Topical Glucocorticosteroids, Journal of the American Academy of Dermatology January Vol. 54, No. 1, P 4

46 BID dosing for most, QD for Fluticasone and Mometasone 30g is needed to cover the entire body of an average age adult Instruct patients in the FTU (Finger Tip Unit) Medication extends from tip to the first joint of the index finger 1 FTU = Hand or groin, 2 FTU s = face or foot, 3 FTU s = arm, 6 FTU s = leg, 14 FTU s = trunk

47 Start with a higher potency steroid for moderate to severe AD When improved after 2 weeks or so step down to a lower potency before stopping If not tapered, AD flares can develop Steroid therapy may be discontinued when inflammation has resolved Continue hydration and emollients Consider twice weekly steroid maintenance Van Der Meer, Br J Dermatol 1999; 140:

48 Tacrolimus (Protopic) and Pimecrolimus (Elidel) Bind to intracellular immunophilins in T-cells Inhibits calcineurin a calcium-ion-calmodulin dependent protein phosphatase necessary for signal transduction Cytokine gene transcription cannot occur Boguniewicz, J Allergy Clin Immunol 2003; 112: S140-50

49 Tacrolimus.03% BID -- Moderate to severe AD, over the age of 2, unresponsive to, or intolerant of, steroids Tacrolimus.1% BID -- As above, over the age of 16 Pimecrolimus 1% BID -- Mild to Moderate AD, over the age of 2, unresponsive to steroids

50 A 2006 black box warning has been issued in the United States based on research that has shown an increase in malignancy in association with the calcineurin inhibitors. While these claims are being investigated further, the medication should likely only be used as indicated (ie, for atopic dermatitis in persons older than 2 y and only when first-line therapy has failed). Primate study with oral pimecrolimus demonstrated development of lymphoma 30x the maximum recommended human dose 2005 ACAAI and AAAAI Calcineurin Inhibitor Task Force Recommend no change in current usage patterns Black Box Warning, Safety of Allergy and Asthma Medicines by Daniel More, MD, About.com Guide Updated July 27, 2007 Elidel and Protopic for the Treatment of Eczema, Black Box Warning on Elidel and Protopic by Daniel More, MD, About.com Guide Updated September 08, 2011 FDA Approves Updated Labeling with Boxed Warning and Medication Guide for Two Eczema Drugs, Elidel and Protopic, January 19, 2006 Fonacier, J Allergy Clin Immunol 2005; 115(6):

51 Phototherapy sunlight in small doses, UV-A, UV- B, a combination of both, psoralen plus UV-A (PUVA), or UV-B1 (narrow-band UV-B) therapy may be used. Long-term adverse effects of skin malignancies in fair-skinned individuals should be weighed against the benefits. Systemic steroids Avoid as much as possible (discontinuing i i usually associated with flares) Interferon Gamma Downregulate Th2 function Cyclosporin systemic calcineurin inhibitor can improve symptoms, but side effects (renal impairment and HTN) limit its use

52 Antimetabolites Mycophenolate, Methotrexate, Azathioprine Psychological Treatment Emotional stressors exacerbate disease Probiotics The rationale for their use is that bacterial products may induce an immune response of the T h 1 series instead of T h 2 and could therefore inhibit the development of allergic IgE antibody production. Some report limited benefit in preventive/therapeutic p roles. This research has yet to be proven. 56 infants with mod-severe AD, randomized to lactobacillus or placebo significant improvemnet in probiotic group after 8 weeks Tar Preparations coal tar is anti-pruritic and antiinflammatory, may induce folliculitis and photosensitivity, use restricted to chronic lesions Michail S. The role of Probiotics in allergic diseases. Allergy Asthma Clin Immunol. Oct ;5(1):5.7 Weston, Arch Dis Child 2005; 90:

53 Omalizumab IgG humanized antibody to binding site on IgE Approved in mod-severe asthma 2 small case series in AD one shows benefit, one shows none Efalizumab Humanized monoclonal antibody to CD11a Blocks T-cells ability to bind to ICAM-1 on antigen presenting cells Approved in mod-severe chronic plaque psoriasis TNF-α Inhibitors (etanercept, infliximab, adalimumab) Blocks migration of T-cells, blocks attraction of TH-2 cells, blocks eosinophil and basophil recruitment Approved in psoriasis and rheumatoid arthritis Lane, J Am Acad Dermatol 2006; 54: Krathen,, J Am Acad Dermatol 2005; 53: Connor, Curr All Asthma Rep 2006; 6:

Skin Manifestations of Allergy

Skin Manifestations of Allergy Dermatologic Manifestations of Allergy William Reisacher MD FACS FAAOA Assistant Professor Weill Cornell Medical College Skin Manifestations of Allergy Atopic dermatitis (atopic eczema, eczema) Contact

More information

Children s Hospital Of Wisconsin

Children s Hospital Of Wisconsin Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,

More information

What is atopic dermatitis?

What is atopic dermatitis? What is atopic dermatitis? Complex inflammatory skin disorder intense pruritus cutaneous hyperreactivity immune dysregulation Chronic with exacerbations and remissions Affects all ages, but more common

More information

Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD)

Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD) Diagnosis: ATOPIC DERMATITIS (AD) Texas Children's Hospital Dermatology Service PCP Referral Guidelines- Atopic Dermatitis (AD) PATIENT ADVICE: Unfortunately, there is no cure for atopic dermatitis, so

More information

Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland

Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland Professor Rohan Ameratunga Clinical Immunologist and Allergist Auckland 16:30-17:25 WS #170: Eczema Management 17:35-18:30 WS #182: Eczema Management (Repeated) Managing ECZEMA A/Prof Rohan Ameratunga

More information

Dermatitis (inflammatory skin condition) Nonallergic. dermatitis. Non-atopic eczema (non- IgE mediated)

Dermatitis (inflammatory skin condition) Nonallergic. dermatitis. Non-atopic eczema (non- IgE mediated) Atopic Eczema Dermatitis (inflammatory skin condition) Allergic dermatitis -eczema Nonallergic dermatitis Atopic eczema (IgE mediated) Non-atopic eczema (non- IgE mediated) Pathophysiology of Eczema Allergy

More information

UPDATES IN ATOPIC DERMATITIS

UPDATES IN ATOPIC DERMATITIS UPDATES IN ATOPIC DERMATITIS Amanda Hess, MMS, PA-C President-Elect, AAPA-AAI Arizona Asthma and Allergy Institute, Scottsdale, AZ LEARNING OBJECTIVES Discuss epidemiology, risk factors, and causes of

More information

ATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS. Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine

ATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS. Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine ATOPIC DERMATITIS: A BLUEPRINT FOR SUCCESS Sierra Wolter MD, FAAD Pediatric Dermatology University of Arizona, College of Medicine THE PLAN Is it atopic dermatitis? What is atopic dermatitis? Guidelines

More information

過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at:

過敏病科中心. Allergy Centre. Eczema. Allergy Centre 過敏病科中心. Allergy Centre. For enquiries and appointments, please contact us at: Allergy Centre 過敏病科中心 Eczema For enquiries and appointments, please contact us at: Allergy Centre 9/F, Li Shu Pui Block Hong Kong Sanatorium & Hospital 2 Village Road, Happy Valley, Hong Kong Tel: 2835

More information

Assessing the Current Treatment of Atopic Dermatitis: Unmet Needs

Assessing the Current Treatment of Atopic Dermatitis: Unmet Needs Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

Atopic Eczema with detail on how to apply wet wraps

Atopic Eczema with detail on how to apply wet wraps Atopic Eczema with detail on how to apply wet wraps Dr Carol Hlela Consultant Dermatologist Head of Unit, Department of Dermatology, Paediatrics Red Cross Children s Hospital, UCT Red Cross War Memorial

More information

Learning Circle: Jan 26, 2011 Childhood Eczema

Learning Circle: Jan 26, 2011 Childhood Eczema Learning Circle: Jan 26, 2011 Childhood Eczema Wingfield Rehmus, MD MPH BC Children s Hospital Clinical Assistant Professor, UBC Department of Paediatrics Associate Member, UBC Department of Dermatology

More information

The Itch That Rashes. Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah

The Itch That Rashes. Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah The Itch That Rashes Sarah D. Cipriano, MD, MPH, MS Resident, Dermatology University of Utah 1 Conflict of Interest No conflict of interest Will discuss off label use of medications 2 3 Most likely diagnosis?

More information

An Everyday Guide to Eczema

An Everyday Guide to Eczema An Everyday Guide to Eczema By Dr. Kristel Polder, Board-Certified Dermatologist Developed in Partnership with Who is affected by eczema? 32 million people in the US 1 in 5 children 1 in 12 adults *www.eczema.org

More information

Contact Dermatitis In Atopic Patients

Contact Dermatitis In Atopic Patients Contact Dermatitis In Atopic Patients Jenny Murase, MD Palo Alto Foundation Medical Group Director of Patch Testing University of California, San Francisco Associate Clinical Professor Disclosures Consultant

More information

RELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN

RELEVANT DISCLOSURES ATOPIC DERMATITIS / ECZEMA MANAGING ECZEMA IN INFANTS AND CHILDREN RELEVANT DISCLOSURES MANAGING ECZEMA IN INFANTS AND CHILDREN Advisory board member - MEDA (Elidel), Speaking honoraria Bayer (Advantan) Advisory board, consultant, speaker: Pfizer, Abbvie, Janssen, Elli

More information

Eczema. Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that makes the problem worse.

Eczema. Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that makes the problem worse. KidsHealth.org The most-visited site devoted to children's health and development Eczema Most kids get itchy rashes at one time or another. But eczema can be a nuisance that may prompt scratching that

More information

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018 Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Policy No: dru493 Topic: Dupixent, dupilumab Date of Origin: March 10, 2017 Committee Approval: March 10, 2017

More information

Understanding. Atopic Dermatitis. National Jewish Health. An educational health series from

Understanding. Atopic Dermatitis. National Jewish Health. An educational health series from Understanding Atopic Dermatitis An educational health series from National Jewish Health If you would like further information about National Jewish Health, please write to: National Jewish Health 1400

More information

Constitutional eczema

Constitutional eczema Patient information Constitutional eczema What is constitutional eczema? Constitutional eczema, also called atopic eczema, is a form of eczema that mainly occurs in childhood. Eczema usually starts before

More information

A Child with Eczema: A Parent s Guide

A Child with Eczema: A Parent s Guide A Child with Eczema: A Parent s Guide What is eczema? Originally the term eczema was used to describe any itchy rash that blistered; now eczema describes skin which is red (inflamed) and intensely itchy.

More information

Eczema & Dermatitis Clinical features: Histopathological features: Classification:

Eczema & Dermatitis Clinical features: Histopathological features: Classification: Eczema & Dermatitis Eczema is an inflammatory reactive pattern of skin to many and different stimuli characterized by itching, redness, scaling and clustered papulovesicles. Eczema and dermatitis are synonymous

More information

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August

CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August BRAND NAME Dupixent GENERIC NAME dupilumab MANUFACTURER Regeneron DATE OF APPROVAL March 28, 2017 PRODUCT LAUNCH DATE First week of April 2017 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review

More information

Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist

Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist Skin Deep: Or is It? Practical Pearls from a Pediatric Dermatologist I have no conflicts of interest 6 yo boy referred for AD. On topical HC and food elimination diet s/p topical triamcinolone to body

More information

ATOPIC ECZEMA. What are the aims of this leaflet?

ATOPIC ECZEMA. What are the aims of this leaflet? ATOPIC ECZEMA What are the aims of this leaflet? This leaflet has been written to help you understand more about atopic eczema. It tells you what it is, what causes it, what can be done about it, and where

More information

Biologic Therapies for Atopic Dermatitis and Beyond

Biologic Therapies for Atopic Dermatitis and Beyond Biologic Therapies for Atopic Dermatitis and Beyond Jonathan Corren, M.D. Departments of Medicine and Pediatrics, David Geffen School of Medicine at UCLA Disclosures Genentech - research Medimmune/AZ -

More information

Managing and Minimizing Flare-ups in Atopic Dermatitis

Managing and Minimizing Flare-ups in Atopic Dermatitis Managing and Minimizing Flare-ups in Atopic Dermatitis Importance of the skin barrier & how commonly used drugs are impacting it Dr. Benjamin Barankin, MD FRCPC Medical Director & Founder of Toronto Dermatology

More information

The Itch That Rashes : An Update on Atopic Dermatitis

The Itch That Rashes : An Update on Atopic Dermatitis The Itch That Rashes : An Update on Atopic Dermatitis By Catherine McCuaig, MD, FRCPC Winter is here and with its arrival the centrally heated air indoors worsens skin dryness, leading to a perturbed epidermal

More information

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria

More information

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm

Allergic Disorders. Allergic Disorders. IgE-dependent Release of Inflammatory Mediators. TH1/TH2 Paradigm Allergic Disorders Anne-Marie Irani, MD Virginia Commonwealth University Allergic Disorders IgE-mediated immune reactions Clinical entities include: asthma allergic rhinitis atopic dermatitis urticaria

More information

The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis

The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis Dermatology The skin is the largest organ of the human body. Functions: protection sensation maintain temperature vitamin synthesis The image to the left shows an image of skin cells and the proteins which

More information

Advisor. Atopic Dermatitis. The Asthma. enter. The Cycle of. Education and Research Fund

Advisor. Atopic Dermatitis. The Asthma. enter. The Cycle of. Education and Research Fund The Asthma C enter Education and Research Fund Advisor a theasthmacenter.org The Cycle of Atopic Dermatitis scratch Introduction Atopic dermatitis (AD), often termed eczema, is a chronic pruritic skin

More information

ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP

ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP Disclosures There are no financial relationships with commercial interests to disclose Ay unlabeled/unapproved

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2116-3 Program Prior Authorization/Medical Necessity Medications Dupixent (dupilumab) P&T Approval Date 1/2017, 5/2017, 7/2017

More information

Pharmacy Benefit Determination Policy

Pharmacy Benefit Determination Policy Policy Subject: Atopic Dermatitis Agents Policy Number: SHS PBD18 Category: Policy Type: Medical Pharmacy Department: Pharmacy Product (check all that apply): Group HMO/POS Individual HMO/POS PPO ASO s:

More information

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio

COMMON SKIN CONDITIONS IN PRIMARY CARE. Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio COMMON SKIN CONDITIONS IN PRIMARY CARE Ibrahim M. Zayneh, MD Dermatology Private Practice, Portsmouth, Ohio DISCLOSURE The Speaker and members of the planning committee do not have a conflict of interest

More information

Atopic Dermatitis: Therapeutic Challenges

Atopic Dermatitis: Therapeutic Challenges Atopic Dermatitis: Therapeutic Challenges PDA August 14, 2009 Jon Hanifin OHSU, Portland Dominant Concepts in Atopic Dermatitis Allergy / Immunology Era: 1915-2006 The Epidermal Era: 2006---- Barrier dysfunction

More information

15 minute eczema consultation

15 minute eczema consultation THERAPY WORKSHOP 15 minute eczema consultation History Current treatments Examination Treatment Plan Written action plan Soap substitute/bath oil Antiseptic baths Emollients Topical steroids Other treatments

More information

Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis

Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis Original Article Comparative efficacy of topical mometasone furoate 0.1% cream vs topical tacrolimus 0.03% ointment in the treatment of atopic dermatitis Md Alauddin Khan *, Lubna Khondker **, Dilshad

More information

Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level

Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level Diagnosis and Management of Common and Infective Skin Diseases in Children at primary care level Dr Ng Su Yuen Paediatrician and Paediatric Dermatologist Hospital Pulau Pinang Outline Common inflammatory

More information

Management of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital

Management of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital Atopic dermatitis definition Management of eczema in infants and children Assoc Prof David Orchard Director, Department of Dermatology Royal Children s Hospital Atopic dermatitis is long lasting (chronic)

More information

Thursday, 21 October :53 - Last Updated Thursday, 11 November :27

Thursday, 21 October :53 - Last Updated Thursday, 11 November :27 1 / 15 2 / 15 3 / 15 4 / 15 Pityriasis Alba Background Pityriasis alba is a nonspecific dermatitis of unknown etiology that causes erythematous scaly patches. These resolve and leave areas of hypopigmentation

More information

Pharmacologic Treatment of Atopic Dermatitis

Pharmacologic Treatment of Atopic Dermatitis J KMA Pharmacotherapeutics Pharmacologic Treatment of Atopic Dermatitis Chun Wook Park, MD Department of Dermatology, Hallym University College of Medicine E mail : dermap@paran.com J Korean Med Assoc

More information

Paediatric Eczema. Dr Manjeet Joshi Consultant Dermatologist 16 th May 2012

Paediatric Eczema. Dr Manjeet Joshi Consultant Dermatologist 16 th May 2012 Paediatric Eczema Dr Manjeet Joshi Consultant Dermatologist 16 th May 2012 Classification of the principal forms of eczema EXOGENOUS ENDOGENOUS Irritant Allergic contact Photoallergic contact Eczematous

More information

Topical Immunomodulator Step Therapy Program

Topical Immunomodulator Step Therapy Program Topical Immunomodulator Step Therapy Program Policy Number: 5.01.557 Last Review: 8/2017 Origination: 7/2013 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) BCBSKC will provide

More information

Eucrisa. Eucrisa (crisaborole) Description

Eucrisa. Eucrisa (crisaborole) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.25 Subject: Eucrisa Page: 1 of 6 Last Review Date: September 15, 2017 Eucrisa Description Eucrisa

More information

CHAPTER 1. Eczema Basics

CHAPTER 1. Eczema Basics CHAPTER 1 Eczema Basics Definition Eczema is an inflammatory skin condition, characterised by ichtyosis (dry skin), erythema (redness), excoriation (interruption of the skin), scratching lesions, lichenification

More information

Note: AD stands for Atopic Dermatitis. Page numbers in italics indicate figures. Page numbers followed by a t indicate tables.

Note: AD stands for Atopic Dermatitis. Page numbers in italics indicate figures. Page numbers followed by a t indicate tables. index Note: AD stands for Atopic Dermatitis. Page numbers in italics indicate figures. Page numbers followed by a t indicate tables. Adolescent-onset AD, 67, 70, 71 ADSI (AD Severity ), 101 Adult-onset

More information

Ailléirge Péidiatraiceach. Pediatric Allergy 3/9/2018. Disclosures & Conflicts Of Interest

Ailléirge Péidiatraiceach. Pediatric Allergy 3/9/2018. Disclosures & Conflicts Of Interest Ailléirge Péidiatraiceach Michael Zacharisen, M.D. Allergy/Immunology Pediatric Allergy Michael Zacharisen, M.D. Allergy/Immunology Disclosures & Conflicts Of Interest Green Bay Packer fan I drive a Jeep

More information

TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal

TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal TRIGGERS & TREATMENT OF ATOPIC DERMATITIS COA#PCIA0809 CE Activity provided by PCI Journal INSTRUCTIONS 1. Read the article. 2. Take the test, record your answers in the test answer section (Section B)

More information

Atopic Dermatitis. Marcia Hogeling, MD Pediatric Dermatologist Phoenix Children s Hospital

Atopic Dermatitis. Marcia Hogeling, MD Pediatric Dermatologist Phoenix Children s Hospital Atopic Dermatitis Marcia Hogeling, MD Pediatric Dermatologist Phoenix Children s Hospital Disclosure slide advisory board for Leo Pharma and Anacor we use some off label medications to treat atopic dermatitis

More information

Eucrisa. Eucrisa (crisaborole) Description

Eucrisa. Eucrisa (crisaborole) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Eucrisa Page: 1 of 7 Last Review Date: June 22, 2018 Eucrisa Description Eucrisa (crisaborole)

More information

New Medicine Report. Pimecrolimus. RED- Hospital only Date of Last Revision 6 th March 2003

New Medicine Report. Pimecrolimus. RED- Hospital only Date of Last Revision 6 th March 2003 New Medicine Report Document Status Pimecrolimus Reviewed by Suffolk D&T RED- Hospital only Date of Last Revision 6 th March 2003 Approved Name Pimecrolimus Trade Name Elidel Manufacturer Novartis Legal

More information

ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP

ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP Disclosures Promotional Speaker for Pfizer, Inc. Any unlabeled/unapproved uses of drugs or products

More information

What to do when patch testing is negative?

What to do when patch testing is negative? What to do when patch testing is negative? Christen M. Mowad MD Clinical Professor of Dermatology Geisinger Medical Center Danville, PA 17821 cmowad@geisinger.edu I have no disclosures. What to do when

More information

What you need to know about ECZEMA

What you need to know about ECZEMA What you need to know about ECZEMA The Irish Skin Foundation is a national charity with a mission to improve quality of life for people with skin conditions, promote skin health and the prevention of skin

More information

Managing Atopic Derma00s: Itching the Night Away. Karol Timmons RN, MS, CPNP Boston Children s Hospital Atopic Derma00s Center

Managing Atopic Derma00s: Itching the Night Away. Karol Timmons RN, MS, CPNP Boston Children s Hospital Atopic Derma00s Center Managing Atopic Derma00s: Itching the Night Away Karol Timmons RN, MS, CPNP Boston Children s Hospital Atopic Derma00s Center Learning Objec-ves Describe common treatments for atopic derma00s including:

More information

ATOPIC DERMATITIS IN CHILDREN. Simple choice questions

ATOPIC DERMATITIS IN CHILDREN. Simple choice questions ATOPIC DERMATITIS IN CHILDREN Simple choice questions 1. Which is the principal cause of atopic dermatitisdevelopment in little age children? A. Psychoemotional factors. B. Habitual antigens. C. Food allergy.

More information

What you need to know about ECZEMA

What you need to know about ECZEMA What you need to know about ECZEMA The Irish Skin Foundation is a national charity with a mission to improve quality of life for people with skin conditions, promote skin health and the prevention of skin

More information

The Epidemiology of Atopic Dermatitis at a Tertiary Referral Skin Center in Singapore

The Epidemiology of Atopic Dermatitis at a Tertiary Referral Skin Center in Singapore ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY (1999) 17: 137-141 The Epidemiology of Atopic Dermatitis at a Tertiary Referral Skin Center in Singapore Yong-Kwang Tay, Boo-Peng Khoo and Chee-Leok Goh

More information

Clinical effectiveness of 6 months cetirizine administration to prevent atopic dermatitis recurrence in children: a randomized trial

Clinical effectiveness of 6 months cetirizine administration to prevent atopic dermatitis recurrence in children: a randomized trial Human & Veterinary Medicine International Journal of the Bioflux Society OPEN ACCESS Research Article Clinical effectiveness of 6 months cetirizine administration to prevent atopic dermatitis recurrence

More information

Itchy babies: Current treatment guidelines for atopic dermatitis

Itchy babies: Current treatment guidelines for atopic dermatitis Itchy babies: Current treatment guidelines for atopic dermatitis Rachel Laarman, MD Helen DeVos Children s Hospital Grand Rapids, MI Photo cred: www.dermatologytimes.modernmedicine.com I have no disclosures

More information

5007 Seminar Advanced Therapeutics: Managing Severe & Refractory Eczema. Part 1. Keys to Adherence: Simplify regimen & Educate

5007 Seminar Advanced Therapeutics: Managing Severe & Refractory Eczema. Part 1. Keys to Adherence: Simplify regimen & Educate 5007 Seminar Advanced Therapeutics: Managing Severe & Refractory Eczema Luz Fonacier, MD Professor of Clinical Medicine State University of New York at Stony Brook Head of Allergy & Training Program Director

More information

Atopic Dermatitis. Atopic dermatitis (AD) is very common with a. Going Skin Deep With. Carl s rashes

Atopic Dermatitis. Atopic dermatitis (AD) is very common with a. Going Skin Deep With. Carl s rashes Focus on CME at Dalhousie University Going Skin Deep With Atopic Dermatitis Scott Murray, MD, FRCP(C), BSc Atopic dermatitis (AD) is very common with a tendency for itching and inflammation of the skin.

More information

Atopic dermatitis Usually starts t in early infancy Xerosis (dry skin) Pruritus Eczematous lesions

Atopic dermatitis Usually starts t in early infancy Xerosis (dry skin) Pruritus Eczematous lesions An Update on Eczema & Common Skin Infections in Children Nelly Rubeiz, MD Dept. of Dermatology American University of Beirut Atopic dermatitis Usually starts t in early infancy Xerosis (dry skin) Pruritus

More information

The safety and effectiveness of Dupixent in pediatric patients have not been established (1).

The safety and effectiveness of Dupixent in pediatric patients have not been established (1). Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.30 Subject: Dupixent Page: 1 of 6 Last Review Date: September 15, 2017 Dupixent Description Dupixent

More information

Clinico Pathological Test SCPA605-Essential Pathology

Clinico Pathological Test SCPA605-Essential Pathology Clinico Pathological Test SCPA605-Essential Pathology Somphong Narkpinit, M.D. Department of Pathogbiology, Faculty of Science, Mahidol University e-mail : somphong.nar@mahidol.ac.th Pathogenesis of allergic

More information

English for Nurses: Eczema Vocabulary allergy allergies be allergic to a bath have a bath to bathe citrus fruits common cool dairy products eczema

English for Nurses: Eczema Vocabulary allergy allergies be allergic to a bath have a bath to bathe citrus fruits common cool dairy products eczema English for Nurses: Eczema Vocabulary allergy allergies be allergic to a bath have a bath to bathe citrus fruits common cool dairy products eczema elbows fingernail a link to link to something make something

More information

Drug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey

Drug allergy and Skin Disorders. Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey Drug allergy and Skin Disorders Timothy Craig, DO, FACOI Professor of Medicine and Pediatrics Distinguished Educator Penn State University, Hershey The best screening test for anaphylaxis is? A. histamine

More information

Time to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service

Time to Learn. 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service Time to Learn 6 th March 2018 Dr. Shirin Chakera GPwSI Integrated Dermatology Service The Red Face Rosacea Acne Seborrhoeic eczema eczema Psoriasis Slapped cheek syndrome Fungal infection Erysipelas...

More information

Atopic Dermatitis Topics discussed

Atopic Dermatitis Topics discussed Dr.F.Shariati Atopic Dermatitis Topics discussed Diagnosis of eczema Incidence Aggravators History and assessment Treatments Clinical Cases Contact details and clinics Eczema = TERMINOLOGY Greek term To

More information

Recommended management of eczema in older patients

Recommended management of eczema in older patients Recommended management of eczema in older patients Victoria Sherman MA, MRCP and Daniel Creamer BSc, MD, FRCP Our series Prescribing in older people gives practical advice for successful management of

More information

Associate Professor Rohan Ameratunga

Associate Professor Rohan Ameratunga Associate Professor Rohan Ameratunga Adult and Paediatric Clinical Immunologist and Allergist Auckland 16:30-17:25 WS #67: Managing Eczema 17:35-18:30 WS #79: Managing Eczema (Repeated) Managing ECZEMA

More information

Allergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children

Allergy Medications. Antihistamines. are very safe. Although usually taken as tablets, they may be prescribed as a liquid or syrup for young children The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient s health, mood and

More information

Recommended diagnosis and management of atopic eczema

Recommended diagnosis and management of atopic eczema n DRUG REVIEW Recommended diagnosis and management of atopic eczema Andrew MacKenzie MRCP(UK) and Olivia Schofield FRCP(Edin) SPL The pathogenesis of atopic eczema is complex and its management requires

More information

TCIs are only available on prescription and are usually started by a dermatology specialist.

TCIs are only available on prescription and are usually started by a dermatology specialist. (TCIs) What are topical calcineurin inhibitors? Topical calcineurin inhibitors are treatments that alter the immune system and have been developed for controlling eczema. There are two types available:

More information

Novel Insights in Atopic Dermatitis: Pathways, Biomarkers, and Phenotypes for a Targeted Approach Transcript

Novel Insights in Atopic Dermatitis: Pathways, Biomarkers, and Phenotypes for a Targeted Approach Transcript Novel Insights in Atopic Dermatitis: Pathways, Biomarkers, and Phenotypes for a Targeted Approach Transcript Title Slide Welcome to the CME-certified program: Novel Insights in Atopic Dermatitis; Pathways,

More information

Dr David Orchard MBBS FACD

Dr David Orchard MBBS FACD Eczema Dr David Orchard MBBS FACD What is eczema? Eczema is a particular type of inflammatory reaction in the skin. The features include redness, scaling and itch. When it is more severe the skin will

More information

Managing Eczema. Eczema Education Series.

Managing Eczema. Eczema Education Series. Managing Eczema Eczema Education Series www.eczemahelp.ca Table of Contents Introduction to Eczema Triangle of Control 1 2 Education What is Eczema? What Causes Eczema? Understanding the Disease Impaired

More information

My Algorithm. Questions to ask. Do you or your family have a history of?... Allergic rhinitis, Sensitive skin, Asthma Skin Cancer

My Algorithm. Questions to ask. Do you or your family have a history of?... Allergic rhinitis, Sensitive skin, Asthma Skin Cancer Tracey C. Vlahovic, DPM Associate Professor, Temple University School of Podiatric Medicine My Algorithm Inflammatory Skin Disorder on Feet Family hx, clinical exam, look at hands! Defined plaques: Psoriasis

More information

Handout on Health: Atopic Dermatitis (A type of eczema)

Handout on Health: Atopic Dermatitis (A type of eczema) Handout on Health: Atopic Dermatitis (A type of eczema) This publication is for people who have atopic dermatitis (often called eczema ), parents and caregivers of children with atopic dermatitis, and

More information

Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57

Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57 Atopic eczema in under 12s: diagnosis and management Clinical guideline Published: 12 December 2007 nice.org.uk/guidance/cg57 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Psoriasis: Causes, Symptoms, And Treatment

Psoriasis: Causes, Symptoms, And Treatment Psoriasis: Causes, Symptoms, And Treatment We all know that a healthy immune system is good. But, do you know that an overactive immune system can cause certain conditions like Psoriasis? Read on to find

More information

Overcoming Persistent Barriers to Effective Management of Atopic Dermatitis

Overcoming Persistent Barriers to Effective Management of Atopic Dermatitis Overcoming Persistent Barriers to Effective Management of Atopic Dermatitis Jack B. Cohen, DO Clinical Professor Department of Dermatology UT Southwestern Medical Center Dallas, TX Atopic Dermatitis I

More information

Eczema. By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University

Eczema. By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University Eczema By:- Dr. Naif Al-Shahrani Salman bin Abdazziz University Dermatitis= Eczema =Spongiosis Eczema Atopic Seborrheic Contact Allergic Irritant Nummular Asteatotic Stasis Neurodermatitis/Lichen Simplex

More information

What s Topical About Topicals?

What s Topical About Topicals? What s Topical About Topicals? Megha M. Tollefson, MD Associate Professor of Dermatology and Pediatrics July 29, 2017 2015 MFMER 3513105-1 Disclosures None 2015 MFMER 3513105-2 Outline Topical steroids

More information

IMMUNODEFICIENCIES PRIMARY ALLERGIES PRIMARY IMMUNODEFICIENCIES AND ALLERGIES

IMMUNODEFICIENCIES PRIMARY ALLERGIES PRIMARY IMMUNODEFICIENCIES AND ALLERGIES PRIMARY IMMUNODEFICIENCIES ALLERGIES PRIMARY IMMUNODEFICIENCIES AND ALLERGIES 1 PRIMARY IMMUNODEFICIENCIES KEY ABBREVIATIONS IgE CID Immunoglobulin E Combined Immunodeficiency IL5 Interleukin 5 IPOPI PID

More information

Treating dermatomyositis

Treating dermatomyositis Treating dermatomyositis David Fiorentino, MD, PhD Stanford University School of Medicine Department of Dermatology Department of Medicine (Rheumatology) September 25, 2010 DM affects many organs Approaching

More information

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough

Vulval dermatoses. Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Vulval dermatoses Dr Fiona Lewis, Consultant Dermatologist St John s Institute of Dermatology, London & Heatherwood & Wexham Park Hospital, Slough Pigmentation Vulvodynia Ulcers Genetic Pruritus VULVAL

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Dupixent) Reference Number: CP.HNMC.208 Effective Date: 04.11.17 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy

More information

Update on emollients

Update on emollients Update on emollients Amal Mhanna, MD Pediatric Dermatologist Clemenceau Medical Center Disclosure: I was a member of an advisory board y for J&J and received honoraria. Emollients and moisturizers are

More information

Atopic dermatitis: tacrolimus vs. topical corticosteroid use

Atopic dermatitis: tacrolimus vs. topical corticosteroid use Atopic dermatitis: tacrolimus vs. topical corticosteroid use Langa Y, BPharm Van der Merwe E, BPharm, MSc (Pharmacology) Correspondence to: Elsabe van der Merwe, e-mail: elsabev@medikredit.co.za Keywords:

More information

Dermatology elective for yr. 5. Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015

Dermatology elective for yr. 5. Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015 Dermatology elective for yr. 5 Natta Rajatanavin, MD. Div. of dermatology Dep. Of Medicine, Ramathibodi Hospital Mahidol University 23 rd Feb 2015 How to diagnosis and manage eczema and psoriasis. Objectives

More information

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010

Coverage Criteria: Express Scripts, Inc. monograph dated 03/03/2010 BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Xolair (omalizumab) Commercial HMO/PPO/CDHP HMO/PPO/CDHP: Rx

More information

8-year surveillance 2016 Atopic eczema in under 12s (2007) NICE guideline CG57

8-year surveillance 2016 Atopic eczema in under 12s (2007) NICE guideline CG57 8-year 2016 Atopic eczema in under 12s (2007) NICE guideline CG57 Appendix A: decision matrix year Diagnosis 57 01 What criteria should be used to diagnose atopic eczema in children and how do they vary

More information

A*STAR skin examination protocol

A*STAR skin examination protocol A*STAR skin examination protocol Professor Carsten Flohr Chair in Dermatology and Population Science & Consultant Dermatologist Unit for Population-Based Dermatology Research St John s Institute of Dermatology

More information

Prospective Trial Comparing Topical Steroid Application To Wet Versus Dry Skin In Children With Atopic Dermatitis

Prospective Trial Comparing Topical Steroid Application To Wet Versus Dry Skin In Children With Atopic Dermatitis Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2014 Prospective Trial Comparing Topical Steroid Application

More information

Atopic Dermatitis and Topical Antipsoriatics

Atopic Dermatitis and Topical Antipsoriatics Atopic Dermatitis and Topical Antipsoriatics Goal(s): Restrict dermatological drugs only for funded OHP diagnoses. Moderate/severe psoriasis and moderate/severe atopic dermatitis treatments are funded

More information

الاكزيماتيد= Eczematid

الاكزيماتيد= Eczematid 1 / 7 2 / 7 Pityriasis Debate confusing of hypopigmentation characterized increasing surrounded differ hypomelanotic "progressive exists alba misnomer extensive a to observed term the applied term derived

More information

COMMON CHILDHOOD SKIN DISEASES. Sharon Seguin MD FAAD

COMMON CHILDHOOD SKIN DISEASES. Sharon Seguin MD FAAD COMMON CHILDHOOD SKIN DISEASES Sharon Seguin MD FAAD COMMON CHILDHOOD SKIN DISEASES Rashes Infections And Infestations RASHES Dermatitis- Inflammation of the skin Eczema- Atopic Dermatitis Psoriasis Pityriasis

More information